ISSN 1671-5411 CN 11-5329/R
Volume 20 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Please cite this article as: ZHENG W, HUANG X, SUO M, WANG X, ZHAO XD, GONG W, YAN Y, WANG XN, SHENG L, NIE SP. Protocol for the FACE study: frailty and comorbidity in elderly patients—a multicenter, Chinese observational cohort study. J Geriatr Cardiol 2023; 20(1): 83−90. DOI: 10.26599/1671-5411.2023.01.009
Citation: Please cite this article as: ZHENG W, HUANG X, SUO M, WANG X, ZHAO XD, GONG W, YAN Y, WANG XN, SHENG L, NIE SP. Protocol for the FACE study: frailty and comorbidity in elderly patients—a multicenter, Chinese observational cohort study. J Geriatr Cardiol 2023; 20(1): 83−90. DOI: 10.26599/1671-5411.2023.01.009

Protocol for the FACE study: frailty and comorbidity in elderly patients—a multicenter, Chinese observational cohort study

doi: 10.26599/1671-5411.2023.01.009
Funds:  The study has been approved by the National Key R & D Program of China (2020YFC2004800).
*The authors contributed equally to this manuscript
More Information
  • Corresponding author:
  • Available Online: 2023-02-06
  • Publish Date: 2023-01-28
  • The present protocol describes an observational cohort study that was designed to propose a therapeutic scheme and formulate an individualized treatment strategy for frail elderly patients diagnosed with multiple diseases in a Chinese, multicenter setting. Over a 3-year period, we will recruit 30,000 patients from 10 hospitals and collect baseline data including patient demographic information, comorbidity characteristic, FRAIL scale, age-adjusted Charlson comorbidity index (aCCI), relevant blood tests, the results of imaging examination, prescription of drugs, length of hospital stay, number of overall re-hospitalizations and death. Elderly patients (≥ 65 years old) with multimorbidity and receiving hospital care are eligible for this study. Data collection is being performed at baseline and 3, 6, 9 and 12 months after discharge. Our primary analysis was all-cause death, readmission rate and clinical events (including emergency visits, stroke, heart failure, myocardial infarction, tumor, acute chronic obstructive pulmonary disease, etc). The study is approved by the National Key R & D Program of China (2020YFC2004800). Data will be disseminated in manuscripts submitted to medical journals and in abstracts submitted to international geriatric conferences. Clinical Trial Registration: [], identifier [ChiCTR2200056070].
  • loading
  • [1]
    Rudnicka E, Napierala P, Podfigurna A, et al. The World Health Organization (WHO) approach to healthy ageing. Maturitas 2020; 139: 6−11. doi: 10.1016/j.maturitas.2020.05.018
    Bencivenga L, Komici K, Nocella P, et al. Atrial fibrillation in the elderly: a risk factor beyond stroke. Ageing Res Rev 2020; 61: 101092. doi: 10.1016/j.arr.2020.101092
    van Onna M, Boonen A. Challenges in the management of older patients with inflammatory rheumatic diseases. Nat Rev Rheumatol 2022; 18: 326−334. doi: 10.1038/s41584-022-00768-6
    Wang Z, Xing Y, Yan W, et al. Effects of individual, family and community factors on the willingness of institutional elder care: a cross-sectional survey of the elderly in China. BMJ Open 2020; 10: e032478. doi: 10.1136/bmjopen-2019-032478
    van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol 2001; 54: 675−679. doi: 10.1016/S0895-4356(00)00358-9
    Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 2016; 66: 337−350. doi: 10.3322/caac.21342
    Lynch CP, Gebregziabher M, Zhao Y, et al. Impact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence. BMC Endocr Disord 2014; 14: 68. doi: 10.1186/1472-6823-14-68
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373−383. doi: 10.1016/0021-9681(87)90171-8
    Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition-multimorbidity. JAMA 2012; 307: 2493−2494.
    Keezer MR, Sander JW. Comorbidity as an epidemiological construct. Lancet Neurol 2016; 15: 32.
    Fan J, Yu C, Guo Y, et al. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study. Lancet Public Health 2020; 5: e650−e660. doi: 10.1016/S2468-2667(20)30113-4
    Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health 2018; 3: e323−e332. doi: 10.1016/S2468-2667(18)30091-4
    Kundi H, Wadhera RK, Strom JB, et al. Association of frailty with 30-day outcomes for acute myocardial infarction, heart failure, and pneumonia among elderly adults. JAMA Cardiol 2019; 4: 1084−1091. doi: 10.1001/jamacardio.2019.3511
    Bekic S, Babic F, Filipcic I, Trtica Majnaric L. Clustering of mental and physical comorbidity and the risk of frailty in patients aged 60 years or more in primary care. Med Sci Monit 2019; 25: 6820−6835. doi: 10.12659/MSM.915063
    Loprinzi PD. Multimorbidity, cognitive function, and physical activity. Age (Dordr) 2016; 38: 8. doi: 10.1007/s11357-016-9874-5
    Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012; 60: 1487−1492. doi: 10.1111/j.1532-5415.2012.04054.x
    Khan KT, Hemati K, Donovan AL. Geriatric physiology and the frailty syndrome. Anesthesiol Clin 2019; 37: 453−474. doi: 10.1016/j.anclin.2019.04.006
    Verspoor E, Voortman T, van Rooij FJA, et al. Macronutrient intake and frailty: the Rotterdam Study. Eur J Nutr 2020; 59: 2919−2928. doi: 10.1007/s00394-019-02131-0
    Hao Q, Wang Y, Ding X, et al. G-395A polymorphism in the promoter region of the KLOTHO gene associates with frailty among the oldest-old. Sci Rep 2018; 8: 6735. doi: 10.1038/s41598-018-25040-4
    Hoogendijk EO, Afilalo J, Ensrud KE, et al. Frailty: implications for clinical practice and public health. Lancet 2019; 394: 1365−1375. doi: 10.1016/S0140-6736(19)31786-6
    Villacampa-Fernandez P, Navarro-Pardo E, Tarin JJ, Cano A. Frailty and multimorbidity: two related yet different concepts. Maturitas 2017; 95: 31−35. doi: 10.1016/j.maturitas.2016.10.008
    Onder G, Palmer K, Navickas R, et al. Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS). Eur J Intern Med 2015; 26: 157−159.
    Yarnall AJ, Sayer AA, Clegg A, et al. New horizons in multimorbidity in older adults. Age Ageing 2017; 46: 882−888. doi: 10.1093/ageing/afx150
    Fuller GF. Falls in the elderly. Am Fam Physician 2000; 61: 2159−2168,2173-2154.
    Regauer V, Seckler E, Muller M, Bauer P. Physical therapy interventions for older people with vertigo, dizziness and balance disorders addressing mobility and participation: a systematic review. BMC Geriatr 2020; 20: 494. doi: 10.1186/s12877-020-01899-9
    Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing 2018; 47: 193−200. doi: 10.1093/ageing/afx162
    Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J 2014; 35: 1726−1731. doi: 10.1093/eurheartj/ehu197
    Chow MR, Ayiotis AI, Schoo DP, et al. Posture, gait, quality of life, and hearing with a vestibular implant. N Engl J Med 2021; 384: 521−532. doi: 10.1056/NEJMoa2020457
    Tapper EB, Finkelstein D, Mittleman MA, et al. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology 2015; 62: 584−590. doi: 10.1002/hep.27830
    Wells A, Reeves D, Capobianco L, et al. Improving the effectiveness of psychological interventions for depression and anxiety in cardiac rehabilitation: PATHWAY-a single-blind, parallel, randomized, controlled trial of group metacognitive therapy. Circulation 2021; 144: 23−33. doi: 10.1161/CIRCULATIONAHA.120.052428
    Mayr R, May M, Martini T, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012; 62: 662−670. doi: 10.1016/j.eururo.2012.03.057
    Courcier J, De La Taille A, Lassau N, Ingels A. Comorbidity and frailty assessment in renal cell carcinoma patients. World J Urol 2021; 39: 2831−2841. doi: 10.1007/s00345-021-03632-6
    Mak JKL, Kuja-Halkola R, Wang Y, et al. Frailty and comorbidity in predicting community COVID-19 mortality in the U. K. Biobank: The effect of sampling. J Am Geriatr Soc 2021; 69: 1128−1139.
    Chen FF, Ye XN, Jiang HT, et al. Role of Frailty and Comorbidity Status in Predicting Morbidity and Mortality in Patients with Acute Mesenteric Ischemia. Ann Vasc Surg 2020; 67: 105−114.
    Dent E, Martin FC, Bergman H, et al. Management of frailty: opportunities, challenges, and future directions. Lancet 2019; 394: 1376−1386.
    Cesari M, Calvani R, Marzetti E. Frailty in Older Persons. Clin Geriatr Med 2017; 33: 293−303. doi: 10.1016/j.cger.2017.02.002
  • 加载中


    通讯作者: 陈斌,
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索


    Article Metrics

    Article views (42) PDF downloads(31) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint